Sebastiani Ventures Corp. announced the terms of the non-brokered private placement financing being conducted in connection with the Company's proposed reverse takeover to acquire EvokAI Creative Labs Inc. On completion of the Acquisition, the Company's Board of Directors and management team will be reconstituted to include four directors and management comprised of individuals from EvokAI and Sebastiani, including the individuals listed below. Alejandro Antalich - Director, Mr. Antalich is the former Chief Executive Officer of the Canadian Company ICC Labs Inc. (TSXV), the first publicly traded company in the world to sell cannabis to a federal government.

Mr. Antalich led ICC Labs to its successful sale to Aurora Cannabis Inc. (TSX) in November 2018, a $300 million transaction. Mr. Antalich is an entrepreneur and investor with a commercial instinct and vision towards business growth, with expertise in the medtech and foodtech sectors, as well in the pharmaceutical industry, operations, manufacturing and product development. Mr. Antalich is also the CEO and a director of Biomind Labs Inc., a Canadian publicly traded life sciences company specializing in fast acting psychedelics and tailored drug delivery systems targeting specific therapeutic indications.

Peter Dickie - Director, Mr. Dickie has spent over 40 years, including acting as an independent business consultant since 2014, in the public and private corporate environment, having served in a variety of management and executive roles in both private and public companies during that time. Mr. Dickie is the former President, CEO, and a director of NioCorp Developments, a company developing the larger super-alloy mineral deposit in North American. Mr. Dickie is a former Registered Investment Advisor with a Canadian securities firm, and a graduate of both the University of Victoria, and the University of British Columbia.